BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19498277)

  • 21. Effects of three antagonists on selected pharmacodynamic effects of sublingually administered detomidine in the horse.
    Knych HK; Stanley SD
    Vet Anaesth Analg; 2014 Jan; 41(1):36-47. PubMed ID: 24134603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of atipamezole, an alpha 2-adrenergic antagonist, and somatostatin on xylazine-induced growth hormone release in calves.
    Kasuya E; Hodate K; Matsumoto M; Sakaguchi M; Hashizume T; Kanematsu S
    Endocr J; 1996 Oct; 43(5):551-6. PubMed ID: 8980895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of the emetic action of xylazine by alpha-adrenoceptor blocking agents.
    Hikasa Y; Takase K; Saito K; Ogasawara S
    Eur J Pharmacol; 1986 Nov; 130(3):229-35. PubMed ID: 2878819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of atipamezole and yohimbine on medetomidine-induced central nervous system depression and cardiorespiratory changes in lambs.
    Ko JC; McGrath CJ
    Am J Vet Res; 1995 May; 56(5):629-32. PubMed ID: 7661459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets.
    Matsukawa T; Hikasa Y
    Am J Vet Res; 2020 Feb; 81(2):159-171. PubMed ID: 31985287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the use of intranasal atipamezole to reverse the sedative effects of xylazine in dogs.
    Focken AP; Woodsworth JM; Loewen JM
    J Vet Emerg Crit Care (San Antonio); 2024; 34(1):57-62. PubMed ID: 38055352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of medetomidine on serum osmolality; urine volume, osmolality and pH; free water clearance; and fractional clearance of sodium, chloride, potassium, and glucose in dogs.
    Burton S; Lemke KA; Ihle SL; Mackenzie AL
    Am J Vet Res; 1998 Jun; 59(6):756-61. PubMed ID: 9622747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
    El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
    Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic effects of alpha-adrenoceptor blocking agents on reticuloruminal hypomotility induced by xylazine in cattle.
    Hikasa Y; Takase K; Emi S; Ogasawara S
    Can J Vet Res; 1988 Oct; 52(4):411-5. PubMed ID: 2904298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia.
    Cabral AD; Kapusta DR; Kenigs VA; Varner KJ
    Am J Physiol; 1998 Dec; 275(6):R1867-74. PubMed ID: 9843875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faster emergence behavior from ketamine/xylazine anesthesia with atipamezole versus yohimbine.
    Mees L; Fidler J; Kreuzer M; Fu J; Pardue MT; García PS
    PLoS One; 2018; 13(10):e0199087. PubMed ID: 30372437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of antagonists for tiletamine-zolazepam/xylazine immobilization in female white-tailed deer.
    Miller BF; Muller LI; Doherty T; Osborn DA; Miller KV; Warren RJ
    J Wildl Dis; 2004 Jul; 40(3):533-7. PubMed ID: 15465721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of intrarenal alpha(2)-adrenoceptors in the renal responses to xylazine in rats.
    Menegaz RG; Kapusta DR; Cabral AM
    Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R1074-81. PubMed ID: 10749797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs.
    Jeunesse E; Woehrle F; Schneider M; Lefebvre HP
    J Vet Cardiol; 2007 Nov; 9(2):63-8. PubMed ID: 18024236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonistic effect of atipamezole on xylazine-induced sedation, bradycardia, and ruminal atony in calves.
    Thompson JR; Kersting KW; Hsu WH
    Am J Vet Res; 1991 Aug; 52(8):1265-8. PubMed ID: 1681769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep.
    Schwartz DD; Clark TP
    J Vet Pharmacol Ther; 1998 Oct; 21(5):342-7. PubMed ID: 9811433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha 2-adrenergic receptor agonist effects on supraventricular and ventricular automaticity in dogs with complete atrioventricular block.
    Day TK; Muir WW
    Am J Vet Res; 1993 Jan; 54(1):136-41. PubMed ID: 8093993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter clinical comparison of sedative and analgesic effects of medetomidine and xylazine in dogs.
    Tyner CL; Woody BJ; Reid JS; Chafetz EP; Lederer HA; Norton JF; Keefe TJ; Jöchle W
    J Am Vet Med Assoc; 1997 Dec; 211(11):1413-7. PubMed ID: 9394891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immobilising free-ranging Alpine chamois with xylazine, reversed with atipamezole.
    Dematteis A; Rossi L; Canavese G; Menzano A; Meneguz PG
    Vet Rec; 2008 Aug; 163(6):184-9. PubMed ID: 18689780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.
    Karhuvaara S; Kallio A; Scheinin M; Anttila M; Salonen JS; Scheinin H
    Br J Clin Pharmacol; 1990 Jul; 30(1):97-106. PubMed ID: 1975199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.